E7090
Showing 1 - 25 of 38
Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)
Recruiting
- Breast Neoplasms
- E7090
- +2 more
-
Nagoya, Aichi, Japan
- +10 more
Nov 11, 2022
Hepatic Impairment Trial in Yufu, Bunkyo-Ku, Minato-Ku (E7090)
Recruiting
- Hepatic Impairment
- E7090
-
Yufu, Oita, Japan
- +2 more
Jan 25, 2022
Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)
Recruiting
- Advanced or Recurrent Solid Tumors
- FGFR Gene Alterations
- E7090
-
Aoba-ku, Sendai, Miyagi, Japan
- +4 more
May 9, 2022
Healthy Participants Trial in Minato-ku (E7090, Rabeprazole 20 mg, Rifampin 600 mg)
Completed
- Healthy Participants
- E7090
- +2 more
-
Minato-ku, Tokoyo, JapanEisai trial site #1
Oct 29, 2021
Tumors Trial in Japan (E7090)
Completed
- Tumors
- E7090
-
Nagoya, Aichi, Japan
- +17 more
Sep 23, 2021
Healthy Volunteers Trial in Leeds ([14C]E7090)
Completed
- Healthy Volunteers
-
Leeds, United KingdomCovance Clinical Research Unit
Feb 3, 2021
Cholangiocarcinoma Trial in China, Japan (E7090)
Active, not recruiting
- Cholangiocarcinoma
- E7090
-
Bengbu, Anhui, China
- +55 more
Jan 24, 2023
Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS) Trial in France, United States (Sutimlimab)
Recruiting
- Cold Agglutinin Disease (CAD)
- Cold Agglutinin Syndrome (CAS)
-
Birmingham, Alabama
- +7 more
Mar 28, 2023
Hepatitis C Positive Organ to Recipient Hepatitis C Negative
Recruiting
- Liver Transplant; Complications
- Hepatitis C
-
New Haven, ConnecticutYale School of Medicine
Mar 21, 2022
Diabetic Ketoacidosis Trial in London (Ringer's lactate)
Recruiting
- Diabetic Ketoacidosis
- Ringer's lactate
-
London, Ontario, CanadaLondon Health Sciences Centre - Victoria Campus
Oct 21, 2022
Immune System Tolerance, Depression, Obesity Trial in Graz (Aronia Juice, Placebo)
Recruiting
- Immune System Tolerance
- +4 more
- Aronia Juice
- Placebo
-
Graz, Styria, AustriaMedical Universtiy of Graz
Jun 20, 2022
Carpal Tunnel Syndrome Trial in Karachi (Soft tissue mobilization, Joint and nerve mobilization)
Recruiting
- Carpal Tunnel Syndrome
- Soft tissue mobilization
- Joint and nerve mobilization
-
Karachi, Sindh, PakistanSindh Institute of Physical Medicine and Rehabilitation
Jul 17, 2022
Respiratory Syncytial Virus Infections Trial in Fukuoka (RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B
- Placebo
-
Fukuoka, JapanGSK Investigational Site
Dec 7, 2021
Carcinoma, Hepatocellular, Metastatic Colorectal Cancer Trial in Bloomsbury (BTG-002814)
Completed
- Carcinoma, Hepatocellular
- Metastatic Colorectal Cancer
-
Bloomsbury, London, United KingdomUniversity College London Hospital
Jul 15, 2021
Healthy Volunteers Trial in San Antonio (Treatment A - 400 mg Fasting, Treatment B - 400 mg Fed, Treatment C - 200 mg Fed)
Completed
- Healthy Volunteers
- Treatment A - 400 mg Fasting
- +2 more
-
San Antonio, TexasWorldwide Clinical Trials
Apr 22, 2020
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Canada, Puerto Rico, United States (Placebo, Tanezumab 2.5 mg, Tanezumab
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Placebo
- +2 more
-
Birmingham, Alabama
- +86 more
Apr 30, 2021
Intestinal Obstruction Trial in Italy (lanreotide (Autogel formulation))
Terminated
- Intestinal Obstruction
- lanreotide (Autogel formulation)
-
Gallipoli, Lecce, Italy
- +12 more
Nov 21, 2019
Epilepsy Trial in Philadelphia (Levetiracetam)
Completed
- Epilepsy
-
Philadelphia, PennsylvaniaDrexel University College of Medicine, Dept of Neurology
Sep 13, 2018
Perinatal Stress on the Development of Preterm Infants
Unknown status
- Premature Birth of Newborn
-
Leuven, Vlaams-Brabant, BelgiumUZLEUVEN
Apr 25, 2019
Low Back Pain Trial in Durham (Physical Activity, Cognitive Behavioral Therapy)
Completed
- Low Back Pain
- Physical Activity
- Cognitive Behavioral Therapy
-
Durham, North CarolinaDurham VA Medical Center, Durham, NC
Sep 4, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Atherosclerotic Cardiovascular Disease Trial in Worldwide (Alirocumab, Placebo, LMT)
Completed
- Atherosclerotic Cardiovascular Disease
- Alirocumab
- +2 more
-
Birmingham, Alabama
- +1387 more
Mar 15, 2019